Oncogenic Myc translocations are independent of chromosomal location and orientation of the immunoglobulin heavy chain locus

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 34, 2012, Pages 13728-13732

  Spehalski, Elizabeth ^a   Kovalchuk, Alexander L ^b   Collins, John T ^a   Liang, Genqing ^c   Dubois, Wendy ^b   Morse III, Herbert C ^b   Ferguson, David O ^a   Casellas, Rafael ^c   Dunnick, Wesley A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN HEAVY CHAIN; MYC PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARCINOGENICITY; CHROMOSOME TRANSLOCATION; CONTROLLED STUDY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE LOCATION; GENE LOCUS; KARYOTYPING; MOUSE; NONHUMAN; PLASMACYTOMA; PRIORITY JOURNAL; TRANSGENE;

ANIMALS; CELL LINE, TUMOR; CHROMOSOME MAPPING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, IMMUNOGLOBULIN HEAVY CHAIN; GENOME; HUMANS; LYMPHOMA, B-CELL; MICE; MICE, INBRED BALB C; MODELS, GENETIC; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS C-MYC; TRANSGENES; TRANSLOCATION, GENETIC;

EID: 84865281601     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1202882109     Document Type: Article

References (41)

1. Nussenzweig A, Nussenzweig MC (2010) Origin of chromosomal translocations in lymphoid cancer. Cell 141:27-38.
2. Gostissa M, Alt FW, Chiarle R (2011) Mechanisms that promote and suppress chromosomal translocations in lymphocytes. Annu Rev Immunol 29:319-350.
3. Cory S (1986) Activation of cellular oncogenes in hemopoietic cells by chromosome translocation. Adv Cancer Res 47:189-234.
4. Potter M (2003) Neoplastic development in plasma cells. Immunol Rev 194:177-195.
5. Janz S (2006) Myc translocations in B cell and plasma cell neoplasms. DNA Repair (Amst) 5:1213-1224.
6. Küppers R, Dalla-Favera R (2001) Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene 20:5580-5594.
7. Cogne M, Birshtein BK (2004) Molecular Biology of B Cells, eds Honjo T, Alt FW, Neuberger MS (Academic, London), pp 289-305.
8. Gostissa M, Ranganath S, Bianco JM, Alt FW (2009) Chromosomal location targets different MYC family gene members for oncogenic translocations. Proc Natl Acad Sci USA 106:2265-2270.
9. Kovalchuk AL, et al. (2007) AID-deficient Bcl-xL transgenic mice develop delayed atypical plasma cell tumors with unusual Ig/Myc chromosomal rearrangements. J Exp Med 204:2989-3001.
10. Rooney S, et al. (2004) Artemis and p53 cooperate to suppress oncogenic N-myc amplification in progenitor B cells. Proc Natl Acad Sci USA 101:2410-2415.
11. Manis JP, Tian M, Alt FW (2002) Mechanism and control of class-switch recombination. Trends Immunol 23:31-39.
12. Muramatsu M, et al. (2000) Class switch recombination and hypermutation require activation- induced cytidine deaminase (AID), a potential RNA editing enzyme. Cell 102:553-563.
13. Revy P, et al. (2000) Activation-induced cytidine deaminase (AID) deficiency causes the autosomal recessive form of the Hyper-IgM syndrome (HIGM2). Cell 102:565-575.
14. Ramiro AR, et al. (2004) AID is required for c-myc/IgH chromosome translocations in vivo. Cell 118:431-438.
15. Dorsett Y, et al. (2007) A role for AID in chromosome translocations between c-myc and the IgH variable region. J Exp Med 204:2225-2232.
16. Robbiani DF, et al. (2008) AID is required for the chromosomal breaks in c-myc that lead to c-myc/IgH translocations. Cell 135:1028-1038.
17. Gostissa M, et al. (2009) Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3′ regulatory region. Nature 462:803-807.
18. Dunnick WA, et al. (2009) Switch recombination and somatic hypermutation are controlled by the heavy chain 3′ enhancer region. J Exp Med 206:2613-2623.
19. Janz S, Müller J, Shaughnessy J, PotterM(1993) Detection of recombinations between c-myc and immunoglobulin switch alpha in murine plasma cell tumors and preneoplastic lesions by polymerase chain reaction. Proc Natl Acad Sci USA 90:7361-7365.
20. Ramiro AR, et al. (2006) Role of genomic instability and p53 in AID-induced c-myc-Igh translocations. Nature 440:105-109.
21. Liyanage M, et al. (2004) Multicolor spectral karyotyping of mouse chromosomes. Nat Genet 14:312-315.
22. Webb E, Adams JM, Cory S (1984) Variant (6; 15) translocation in a murine plasmacytoma occurs near an immunoglobulin κ gene but far from the myc oncogene. Nature 312:777-779.
23. Siwarski D, et al. (1997) Structure and expression of the c-Myc/Pvt 1 megagene locus. Curr Top Microbiol Immunol 224:67-72.
24. Yamane A, et al. (2011) Deep-sequencing identification of the genomic targets of the cytidine deaminase AID and its cofactor RPA in B lymphocytes. Nat Immunol 12:62-69.
25. Huppi K, Pitt J, Wahlberg B, Caplen NJ (2011) Genomic instability and mouse micro- RNAs. Toxicol Mech Methods 21:325-333.
26. Klein IA, et al. (2011) Translocation-capture sequencing reveals the extent and nature of chromosomal rearrangements in B lymphocytes. Cell 147:95-106.
27. Chiarle R, et al. (2011) Genome-wide translocation sequencing reveals mechanisms of chromosome breaks and rearrangements in B cells. Cell 147:107-119.
28. Dunnick WA, Shi J, Graves KA, Collins JT (2004) Germline transcription and switch recombination of a transgene containing the entire H chain constant region locus: Effect of a mutation in a STAT6 binding site in the ã 1 promoter. J Immunol 173:5531-5539.
29. Hakim O, et al. (2012) DNA damage defines sites of recurrent chromosomal translocations in B lymphocytes. Nature 484:69-74.
30. Hasham MG, et al. (2010) Widespread genomic breaks generated by activation-induced cytidine deaminase are prevented by homologous recombination. Nat Immunol 11:820-826.
31. Zhang Y, et al. (2012) Spatial organization of the mouse genome and its role in recurrent chromosomal translocations. Cell 148:908-921.
32. Meaburn KJ, Misteli T, Soutoglou E (2007) Spatial genome organization in the formation of chromosomal translocations. Semin Cancer Biol 17:80-90.
33. Parada LA, McQueen PG, Munson PJ, Misteli T (2002) Conservation of relative chromosome positioning in normal and cancer cells. Curr Biol 12:1692-1697.
34. Roix JJ, McQueen PG, Munson PJ, Parada LA, Misteli T (2003) Spatial proximity of translocation-prone gene loci in human lymphomas. Nat Genet 34:287-291.
35. Osborne CS, et al. (2007) Myc dynamically and preferentially relocates to a transcription factory occupied by Igh. PLoS Biol 5:e192.
36. Liu M, et al. (2008) Two levels of protection for the B cell genome during somatic hypermutation. Nature 451:841-845.
37. Madisen L, Groudine M (1994) Identification of a locus control region in the immunoglobulin heavy-chain locus that deregulates c-myc expression in plasmacytoma and Burkitt's lymphoma cells. Genes Dev 8:2212-2226.
38. Truffinet V, et al. (2007) The 3′ IgH locus control region is sufficient to deregulate a c-myc transgene and promote mature B cell malignancies with a predominant Burkitt-like phenotype. J Immunol 179:6033-6042.
39. Duan H, Heckman CA, Boxer LM (2007) The immunoglobulin heavy-chain gene 3′ enhancers deregulate bcl-2 promoter usage in t(14;18) lymphoma cells. Oncogene 26: 2635-2641.
40. Pelanda R, et al. (1997) Receptor editing in a transgenic mouse model: Site, efficiency, and role in B cell tolerance and antibody diversification. Immunity 7: 765-775.
41. Grillot DAM, et al. (1996) bcl-x exhibits regulated expression during B cell development and activation and modulates lymphocyte survival in transgenic mice. J Exp Med 183:381-391.